Metalloproteinase inhibitors

Details Metalloproteinase inhibitors Metalloproteinase inhibitors

2007-10-30

2009-12-01

Shameem, Golam M. M. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S300100

Reexamination Certificate

active

07625934

ABSTRACT:
Compounds of the formula (I) wherein z is SO2or SO, useful as metalloproteinase inhibitors, especially as inhibitors of MMP12.

REFERENCES:
patent: 3529019 (1970-09-01), Suh, et. al.
patent: 7132434 (2006-11-01), Eriksson et al.
patent: 7354940 (2008-04-01), Henriksson et al.
patent: 7368465 (2008-05-01), Eriksson et al.
patent: 7427631 (2008-09-01), Eriksson et al.
patent: 2003/0130273 (2003-07-01), Sheppeck et al.
patent: 2004/0106659 (2004-06-01), Af Rosenschold
patent: 2004/0110809 (2004-06-01), Lepisto et al.
patent: 2004/0116486 (2004-06-01), Lepisto et al.
patent: 2004/0138276 (2004-07-01), Eriksson et al.
patent: 2004/0147573 (2004-07-01), Eriksson et al.
patent: 2005/0026990 (2005-02-01), Eriksson et al.
patent: 2005/0245586 (2005-11-01), Henriksson et al.
patent: 2005/0256176 (2005-11-01), Burrows et al.
patent: 2006/0063818 (2006-03-01), Burrows et al.
patent: 2006/0276524 (2006-12-01), Henriksson et al.
patent: 2008/0004317 (2008-01-01), Gabos et al.
patent: 2008/0032997 (2008-02-01), Gabos et al.
patent: 2008/0064710 (2008-03-01), Gabos et al.
patent: 2008/0221139 (2008-09-01), Chapman et al.
patent: 2008/0262045 (2008-10-01), Eriksson et al.
patent: 2008/0293743 (2008-11-01), Gabos et al.
patent: 2008/0306065 (2008-12-01), Eriksson et al.
patent: WO 00/09103 (1999-08-01), None
patent: WO 02/074748 (2002-09-01), None
patent: WO 02/074749 (2002-09-01), None
patent: WO 02/074750 (2002-09-01), None
patent: WO 02/074751 (2002-09-01), None
patent: WO 02/074752 (2002-09-01), None
patent: WO 02/074767 (2002-09-01), None
patent: WO 02/096426 (2002-12-01), None
patent: WO 03/040098 (2003-05-01), None
patent: WO 2004/020415 (2004-03-01), None
patent: WO 2004/024698 (2004-03-01), None
patent: WO 2004/024718 (2004-03-01), None
patent: WO 2004/024721 (2004-03-01), None
patent: WO 2006/004532 (2006-01-01), None
patent: WO 2006/004533 (2006-01-01), None
patent: WO 2006/065215 (2006-06-01), None
patent: WO 2006/065216 (2006-06-01), None
patent: WO 2007/106021 (2007-09-01), None
patent: WO 2007/106022 (2007-09-01), None
Griffith “Cysteinesulfinate Metabolism: Altered partitioning between transamination and decarboxylation following administration of β-methyleneaspartate” J. Biol. Chem. 1983 (258) 1591-1598.
Lora-Tamayo et al. “Anticancerousos Potenciales.” An. Quim. 1968 (64) 591-606.
Mosher “Potential Anticancer Agents. VI. Synthesis of α-Amino-γ-sulfamoylbutyric Acids with Substituents on the Sulfonamide Nitrogen” J. Org. Chem. 1958 (23) 1257-1261.
STN International, File CAPLUS, CAPLUS accession No. 1968:506154, Doc. No. 69:106154, Lora-Tamayo, J. et al. “Potential anticancer agents, VI. Sulfonic analogs of aspartic acid” & An. Quim. 1968 (64) 591-606
Whittaker et al. “Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors.” Chem Rev. 1999 (99) 2735-2776.

Affiliated with

Also associated with

Rating

Metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4102723